Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enzo Biochem, Inc. | EZB | Sep 26, 2024 | 1.00 | +1.02 |
Enzymatica | EN9 | Sep 26, 2024 | 0.14 | -12.16 |
EO2 | EO4 | Sep 26, 2024 | 4.05 | -1.94 |
EOG Resources, Inc. | EO5 | Sep 26, 2024 | 107.12 | -5.20 |
Eolus Vind B | 7EVB | Sep 26, 2024 | 4.40 | +0.23 |
EPAM Systems, Inc. | E3M | Sep 26, 2024 | 178.20 | +1.16 |
EPE Special Opportunities Limited | EP0 | Sep 26, 2024 | 1.79 | -0.56 |
EPENDION AB SK 0,3333 | TW4 | Sep 26, 2024 | 9.98 | +0.30 |
Epigenomics AG | ECX | Sep 26, 2024 | 0.65 | 0.00 |
Epiroc A | 3AD1 | Sep 26, 2024 | 18.56 | +3.11 |
EPIROC AB UNSP.ADR/1 | 3ADA | Sep 26, 2024 | 17.60 | -0.57 |
Epiroc B | 3AD2 | Sep 26, 2024 | 16.16 | +2.34 |
Episurf Medical B | 16E | Sep 26, 2024 | 0.00 | 0.00 |
ePlay Digital Inc | 2NY2 | Sep 26, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Sep 26, 2024 | 86.50 | 0.00 |
EPR Properties | E2H | Sep 26, 2024 | 43.94 | +0.24 |
EPRCOMUNICAZIONE S.P.A. | J3P | Sep 26, 2024 | 0.94 | +1.08 |
EPTI AB AK | G7H0 | Sep 26, 2024 | 2.07 | -8.81 |
Epwin Group Plc | 2E3 | Sep 26, 2024 | 1.21 | +0.83 |
EQB INC. | V22 | Sep 26, 2024 | 69.00 | +1.47 |
EQL Pharma | 7JK | Sep 26, 2024 | 4.74 | +1.94 |
EQT | 6EQ | Sep 26, 2024 | 30.60 | -0.13 |
EQT Corporation | EQ6 | Sep 26, 2024 | 31.43 | -0.82 |
Eqtec | KEU | Sep 26, 2024 | 0.01 | +14.29 |
Equals Group Plc | 2FX | Sep 26, 2024 | 1.43 | -0.69 |
Equatorial Resources Limited | PBU | Sep 26, 2024 | 0.06 | 0.00 |
Equifax, Inc. | EFX | Sep 26, 2024 | 262.00 | -1.50 |
Equillium, Inc. | 0FY | Sep 26, 2024 | 0.69 | +0.58 |
Equinix, Inc. | EQN2 | Sep 26, 2024 | 797.60 | +1.30 |
Equinor | DNQ | Sep 26, 2024 | 21.81 | -2.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.